Live Breaking News & Updates on Roberts Langer

Stay updated with breaking news from Roberts langer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Advancing Trials for Hearing Loss

Scientists at Frequency Therapeutics were the first to demonstrate that therapeutic concentrations of FX-322 in the human cochlea are associated with statistically significant improvements in hearing function. These clinical trials administered the therapeutic to one ear, while the other ear in the same participant was used as a control and measured the percentage of participants that exceeded an absolute 10% improvement in speech perception. ....

Roberts Langer , Carl Lebel , Jeffrey Karp , Kevin Franck , Harvard Medical School , Frequency Therapeutics , Chris Loose ,